FTLD-tau Subtypes and Mechanisms

📖 Wiki Page

mechanism1070 wordssynced 2026-04-02

FTLD-tau Subtypes and Mechanisms

Overview

Frontotemporal Lobar Degeneration with tau proteinopathy (FTLD-tau) represents the second most common pathological subgroup of frontotemporal dementia, accounting for approximately 40-45% of all FTD cases. This group encompasses several distinct clinicopathological entities characterized by the accumulation of abnormal tau protein within neurons and glia.

Unlike FTLD-TDP, which primarily involves TDP-43 proteinopathy, FTLD-tau disorders are linked to mutations in the [MAPT](/genes/mapt) gene and share overlapping features with other 4R tauopathies including [corticobasal degeneration](/diseases/corticobasal-degeneration) and [progressive supranuclear palsy](/diseases/progressive-supranuclear-palsy).

FTLD-tau Classification

Major Subtypes

| Subtype | Primary Tau Species | Key Pathology | Clinical Correlates |
|---------|---------------------|---------------|---------------------|
| Pick's disease | 3R tau | Pick bodies, ballooned neurons | bvFTD, svPPA |
| Corticobasal degeneration | 4R tau | astrocytic plaques, oligodendroglial coils | CBS, PSP phenotypes |
| Progressive supranuclear palsy | 4R tau | globose NFTs, tufted astrocytes | PSP syndrome |
| MAPT mutation-associated | 3R/4R mixed | variable inclusions | bvFTD, nfvPPA, parkinsonism |
| Argyrophilic grain disease | 4R tau | argyrophilic grains, coiled bodies |bvFTD, amnestic syndromes |

Pathological Features

...

FTLD-tau Subtypes and Mechanisms

Overview

FTLD-tau Classification

Major Subtypes

Pathological Features

Mermaid diagram (expand to render)

Pick's Disease

Clinical Features

Pick's disease is characterized by progressive behavioral and language changes that typically present in the 5th-7th decade. The clinical presentation often overlaps with bvFTD, with prominent features including:

Behavioral disinhibition and loss of social conduct
Apathy and reduced initiative
Compulsive behaviors and ritualistic movements
Hyperorality and dietary changes
Language impairment that may progress to mutism

Pathological Hallmarks

Pick bodies: spherical, argyrophilic inclusions composed of 3R tau isoforms
Ballooned neurons (Pick cells): swollen, achromatic neurons
Cortical atrophy predominantly affecting frontal and anterior temporal lobes
Neuronal loss and gliosis in affected regions

Genetics

Typically sporadic, though familial cases occur
[MAPT](/genes/mapt) mutations can produce Pick-like pathology
No specific gene definitively linked to classic Pick's disease

Corticobasal Degeneration (CBD)

Clinical Features

[CBD](/diseases/corticobasal-degeneration) presents with a spectrum of motor and cognitive symptoms:

Asymmetric parkinsonism with rigidity and bradykinesia
Cortical sensory loss (astereognosis, tactile neglect)
Ideomotor apraxia and alien limb phenomena
Cognitive impairment ranging from executive dysfunction to frank dementia
Speech impairment including nonfluent/agrammatic patterns

Pathological Features

Astrocytic plaques: distinctive tau-positive astrocytic processes
Oligodendroglial coiled bodies: tau inclusions in oligodendrocytes
Neuronal loss and gliosis in basal ganglia, brainstem
4R tau predominance in all inclusions

Genetics

[MAPT](/genes/mapt) H1 haplotype is a significant risk factor
Specific [MAPT](/genes/mapt) mutations (e.g., P301S, R5H) associated with CBD-like pathology
Recent evidence suggests [GRN](/genes/grn) mutations can also produce CBD pathology

Progressive Supranuclear Palsy (PSP)

Clinical Features

[PSP](/diseases/progressive-supranuclear-palsy) typically presents in the 6th-7th decade:

Vertical supranuclear gaze palsy (downgaze > upgaze)
Postural instability with backward falls
Akinetic-rigid parkinsonism with axial rigidity
Cognitive impairment including executive dysfunction and behavioral changes
Speech disturbances ranging from dysarthria to mutism

Pathological Features

Globose neurofibrillary tangles: tau inclusions in brainstem nuclei
Tufted astrocytes: characteristic astrocytic tau pathology
Neuronal loss in substantia nigra, globus pallidus
4R tau isoform predominance

Genetics

[MAPT](/genes/mapt) H1 haplotype is the major genetic risk factor
[MAPT](/genes/mapt) mutations can cause PSP-like pathology
Rare cases linked to [C9orf72](/genes/c9orf72) expansions

Argyrophilic Grain Disease (AGD)

Clinical Features

AGD is increasingly recognized as a common cause of late-onset behavioral changes:

Behavioral variant FTD features in many cases
Amnestic presentations mimicking Alzheimer's disease
Late-onset psychosis and hallucinations
Slow progression compared to other FTLD subtypes

Pathological Features

Argyrophilic grains: spindle-shaped tau inclusions in neuronal processes
Coiled bodies: oligodendroglial tau inclusions
4R tau in all pathology
Often co-exists with AD-type pathology

MAPT Mutation-Associated Tauopathies

Common Mutations

| Mutation | Primary Phenotype | Pathology | Tau Isoforms |
|----------|------------------|-----------|---------------|
| P301L | bvFTD, PSP | Mixed 3R/4R | 3R + 4R |
| P301S | CBD | 4R predominant | 4R |
| R406W | AD-like | Mixed | 3R + 4R |
| G272V | bvFTD | 3R predominant | 3R |
| ΔN296 | PSP-like | 4R | 4R |

Pathological Mechanisms

[MAPT](/genes/mapt) mutations lead to tau dysfunction through:

Impaired microtubule binding and stabilization
Enhanced aggregation propensity
Altered splicing patterns leading to isoform imbalances
Dysregulated post-translational modifications

Relationship to Other FTLD Subtypes

FTLD-tau and FTLD-TDP Overlap

Mermaid diagram (expand to render)

Clinical-Pathological Correlations

| Clinical Syndrome | Most Common Pathology |
|------------------|----------------------|
| bvFTD | FTLD-tau (Pick's) or FTLD-TDP (type A/B) |
| svPPA | FTLD-TDP type C |
| nfvPPA/CBS | FTLD-tau (CBD) or FTLD-TDP (type A) |
| PSP syndrome | FTLD-tau (PSP) |
| FTD-ALS | FTLD-TDP type B |

Therapeutic Implications

Disease-Modifying Strategies

Anti-tau therapies in development:

Antibodies targeting tau aggregation: Longeveron, ABBV-0805
Small molecule tau aggregation inhibitors: Methylene blue derivatives
Tau kinase inhibitors: GSK-3β, CDK5 inhibitors
Microtubule stabilizers: Davunetide, TPI-287

Clinical Trial Considerations

Pathological heterogeneity requires biomarker-based patient selection
[MAPT](/genes/mapt) mutation carriers may benefit from genotype-specific approaches
Combination therapies targeting both tau and complementary pathways (e.g., neuroinflammation) show promise

Cross-References

[Frontotemporal Dementia](/diseases/frontotemporal-dementia)
[Behavioral Variant FTD](/diseases/behavioral-variant-frontotemporal-dementia)
[Semantic Variant PPA](/diseases/semantic-variant-primary-progressive-aphasia)
[Nonfluent/Agrammatic PPA](/diseases/nonfluent-agrammatic-ppa)
[FTLD-TDP Subtypes](/mechanisms/ftld-tdp-subtypes-mechanisms)
[Corticobasal Degeneration](/diseases/corticobasal-degeneration)
[Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
[Pick's Disease](/diseases/pick-disease)
[MAPT Gene](/genes/mapt)
[Tau Protein](/proteins/tau)

References

[Chickering et al., Neuropathological criteria for Pick disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37294913/)

[Dickson et al., Neuropathology of FTLD variants (2009)](https://pubmed.ncbi.nlm.nih.gov/19547956/)

[Argyrophilic grain disease: Fourth commonest tauopathy (2020)](https://pubmed.ncbi.nlm.nih.gov/32062925/)

[Seeley et al., Selective functional imaging of FTD subtypes (2008)](https://pubmed.ncbi.nlm.nih.gov/18559350/)

[Gorno-Tempini et al., Neural correlates of PPA variants (2004)](https://pubmed.ncbi.nlm.nih.gov/15556759/)

[Lowe et al., Cortico-basal degeneration: cortex to basal ganglia (2017)](https://pubmed.ncbi.nlm.nih.gov/28980603/)

[Kouri et al., Corticobasal degeneration as 4R tauopathy (2011)](https://pubmed.ncbi.nlm.nih.gov/21832176/)

[Boeve et al., CBD and PSP spectrum (2005)](https://pubmed.ncbi.nlm.nih.gov/16030096/)

[Williams et al., Tau pathology in PSP and CBD (2005)](https://pubmed.ncbi.nlm.nih.gov/15972639/)

📖 View canonical wiki page →